New cancer clinical trial: Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Lung Cancer

Published on: December 25, 2017 at 10:00AM
Condition:   Extensive Stage Small Cell Lung Carcinoma
Interventions:   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab
Sponsor:   National Cancer Institute (NCI)
Not yet recruiting
http://ift.tt/2pCS9OZ